Concepedia

Anemone Finck

AF

Statistics

Publications

3

Citations

340

H-Index

3

Active since

2006

Affiliations

Jena University Hospital(Current)

Heidelberg University

Philipps University of Marburg

University of Tübingen

University of Freiburg

Anemone Finck is an author at Jena University Hospital specializing in acute myeloid leukemia treatment, flt3 inhibitors, and acute myeloid leukemia therapy.

Publications per year

2006–2017

3

Publications

3

High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses

Stephan Metzelder, Thomas Schroeder, Anemone Finck et al. · Leukemia · 2012 · 225 citations

, , +15

Long-term survival of sorafenib-treated FLT3-ITD–positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation

Stephan Metzelder, Thomas Schroeder, Michael Lübbert et al. · European Journal of Cancer · 2017 · 68 citations

, , +9

Linkage of autosomal-dominant common variable immunodeficiency to chromosome 4q

Anemone Finck, J.W.M. van der Meer, Alejandro A. Schäffer et al. · European Journal of Human Genetics · 2006 · 47 citations

, , +11

1–3 of 3